Velarion Records
Free. Unsubscribe any time.

Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Inc. filed 32 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 44 transactions and 474,690 shares. 32 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Beam Therapeutics Inc. 44

Adoption dates in Beam Therapeutics Inc. 13

Results prints in Beam Therapeutics Inc. 9

Trades before a print in Beam Therapeutics Inc. 1

Interval to Beam Therapeutics Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Beam Therapeutics Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.